{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:25:32Z","timestamp":1794000332670,"version":"4.8.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.biopha.2018.11.083","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T01:20:24Z","timestamp":1543368024000},"page":"2210-2217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The depletion of PHF6 decreases the drug sensitivity of T-cell acute lymphoblastic leukemia to prednisolone"],"prefix":"10.1016","volume":"109","author":[{"given":"Jinfeng","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2018.11.083_bib0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.biopha.2018.11.083_bib0010","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1172\/JCI61269","article-title":"The molecular basis of T cell acute lymphoblastic leukemia","volume":"122","author":"Van Vlierberghe","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.biopha.2018.11.083_bib0015","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1158\/2159-8290.CD-15-0675","article-title":"Triggering the TCR developmental checkpoint activates a therapeutically targetable tumor suppressive pathway in T-cell leukemia","volume":"6","author":"Trinquand","year":"2016","journal-title":"Cancer Discov."},{"issue":"9617","key":"10.1016\/j.biopha.2018.11.083_bib0020","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","article-title":"Acute lymphoblastic leukaemia","volume":"371","author":"Pui","year":"2008","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.biopha.2018.11.083_bib0025","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","article-title":"The genetics and molecular biology of T-ALL","volume":"129","author":"Girardi","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.biopha.2018.11.083_bib0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccr.2012.06.007","article-title":"Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia","volume":"22","author":"Sanda","year":"2012","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.biopha.2018.11.083_bib0035","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1038\/leu.2010.204","article-title":"NOTCH1 and\/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols","volume":"24","author":"Zuurbier","year":"2010","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.biopha.2018.11.083_bib0040","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm.3078","article-title":"Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL","volume":"19","author":"Tzoneva","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2018.11.083_bib0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuropharm.2017.06.007","article-title":"PTEN, a negative regulator of PI3K\/Akt signaling, sustains brain stem cardiovascular regulation during mevinphos intoxication","volume":"123","author":"Tsai","year":"2017","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.biopha.2018.11.083_bib0050","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","article-title":"Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia","volume":"13","author":"Palomero","year":"2007","journal-title":"Nat. Med."},{"issue":"26","key":"10.1016\/j.biopha.2018.11.083_bib0055","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1200\/JCO.2009.22.0996","article-title":"Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII\/ECOG E2993 protocol","volume":"27","author":"Mansour","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.biopha.2018.11.083_bib0060","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/leu.2010.203","article-title":"The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function","volume":"24","author":"Kox","year":"2010","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.biopha.2018.11.083_bib0065","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/leu.2010.205","article-title":"NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951","volume":"24","author":"Clappier","year":"2010","journal-title":"Leukemia"},{"issue":"1-2","key":"10.1016\/j.biopha.2018.11.083_bib0070","first-page":"3","article-title":"PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks","volume":"647","author":"Baker","year":"2008","journal-title":"Mutat. Res."},{"issue":"10","key":"10.1016\/j.biopha.2018.11.083_bib0075","doi-asserted-by":"crossref","first-page":"6630","DOI":"10.1074\/jbc.M114.610196","article-title":"Structural basis of plant homeodomain finger 6 (PHF6) recognition by the retinoblastoma binding protein 4 (RBBP4) component of the nucleosome remodeling and deacetylase (NuRD) complex","volume":"290","author":"Liu","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.biopha.2018.11.083_bib0080","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1021\/pr3004369","article-title":"PHF6 interacts with the nucleosome remodeling and deacetylation (NuRD) complex","volume":"11","author":"Todd","year":"2012","journal-title":"J. Proteome Res."},{"issue":"4","key":"10.1016\/j.biopha.2018.11.083_bib0085","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ng1040","article-title":"Mutations in PHF6 are associated with Borjeson-Forssman-Lehmann syndrome","volume":"32","author":"Lower","year":"2002","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.biopha.2018.11.083_bib0090","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3892\/ol.2016.4581","article-title":"Co-existence of PHF6 and NOTCH1 mutations in adult T-cell acute lymphoblastic leukemia","volume":"12","author":"Li","year":"2016","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.biopha.2018.11.083_bib0095","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3324\/haematol.2013.099515","article-title":"MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia","volume":"99","author":"Mets","year":"2014","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.biopha.2018.11.083_bib0100","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng.542","article-title":"PHF6 mutations in T-cell acute lymphoblastic leukemia","volume":"42","author":"Van Vlierberghe","year":"2010","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.biopha.2018.11.083_bib0105","doi-asserted-by":"crossref","first-page":"991","DOI":"10.4155\/fmc.13.56","article-title":"Small-molecule inhibitors of p21 as novel therapeutics for chemotherapy-resistant kidney cancer","volume":"5","author":"Liu","year":"2013","journal-title":"Future Med. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2018.11.083_bib0110","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1074\/jbc.M112.414839","article-title":"PHF6 regulates cell cycle progression by suppressing ribosomal RNA synthesis","volume":"288","author":"Wang","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.biopha.2018.11.083_bib0115","doi-asserted-by":"crossref","first-page":"10069","DOI":"10.1074\/jbc.M113.535351","article-title":"Structural and functional insights into the human Borjeson-Forssman-Lehmann syndrome-associated protein PHF6","volume":"289","author":"Liu","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2018.11.083_bib0120","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood.V94.4.1209","article-title":"Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia","volume":"94","author":"Dordelmann","year":"1999","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.biopha.2018.11.083_bib0125","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1182\/blood-2002-08-2454","article-title":"Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children\u2019s Cancer Group","volume":"101","author":"Bostrom","year":"2003","journal-title":"Blood"},{"issue":"27","key":"10.1016\/j.biopha.2018.11.083_bib0130","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1200\/JCO.2005.01.982","article-title":"No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children\u2019s Cancer Study Group L95-14 protocol","volume":"23","author":"Igarashi","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2018.11.083_bib0135","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.3892\/ol.2017.6716","article-title":"NHE1 has a notable role in metastasis and drug resistance of T-cell acute lymphoblastic leukemia","volume":"14","author":"Altaf","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2018.11.083_bib0140","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1038\/bcj.2014.52","article-title":"A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia","volume":"4","author":"Samuels","year":"2014","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.biopha.2018.11.083_bib0145","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1038\/srep05260","article-title":"Identification of temozolomide resistance factors in glioblastoma via integrative miRNA\/mRNA regulatory network analysis","volume":"4","author":"Hiddingh","year":"2014","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2018.11.083_bib0150","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1101\/gad.295857.117","article-title":"PHF6 regulates phenotypic plasticity through chromatin organization within lineage-specific genes","volume":"31","author":"Soto-Feliciano","year":"2017","journal-title":"Genes Dev."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218362607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218362607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:35:23Z","timestamp":1777876523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218362607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":30,"alternative-id":["S0753332218362607"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.11.083","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The depletion of PHF6 decreases the drug sensitivity of T-cell acute lymphoblastic leukemia to prednisolone","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.11.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}